Table 5 OR (95% CI) for moderate‐to‐high disease activity score of 28 joints (DAS28>3.2) in patients with rheumatoid arthritis according to the presence of metabolic syndrome components.
| Metabolic syndrome | Increased disease activity (DAS28 >3.20) | |||
|---|---|---|---|---|
| Age‐adjusted and sex‐adjusted* | Multivariate‐adjusted† | |||
| Components | OR (95% CI) | p Value | OR (95% CI) | p Value |
| None | 1.00 (reference) | — | 1.00 (reference) | — |
| 1–2 | 2.44 (0.70 to 8.44) | 0.160 | 1.82 (0.49 to 6.72) | 0.370 |
| ⩾3 | 12.1 (2.1 to 71.1) | 0.006 | 9.24 (1.49 to 57.2) | 0.016 |
| p for trend 0.004 | p for trend 0.011 | |||
DAS28, disease activity score of 28 joints; MetS, metabolic syndrome.
*Logistic regression for increased DAS28 (>3.20) including age, sex and number of MetS risk factors (0, 1–2 or ⩾3) as independent variables.
†Logistic regression for increased DAS28 (>3.20) including age, sex, number of MetS risk factors (0, 1–2, or ⩾3), use of biologicals/steroids/methotrexate, smoking and body mass index (<25, 25.1–29.9, ⩾30 kg/m2) as independent variables.